#alkem-laboratories

Alkem Laboratories launches NeuCeno for partial-onset seizures in adults

The once-daily oral therapy is available in five strengths, with clinical studies showing reductions in seizure frequency among adults with uncontrolled focal seizures

Buy Alkem Laboratories ; target of Rs 6850 : ICICI Securities

Broker Call : Alkem Laboratories ( Add ) - The HinduBusinessLine

Alkem Laboratories shares jump after Q4 revenue growth and upbeat FY27 outlook

Shares of Alkem Laboratories surged over 6 per cent in early trade on Friday after the company reported strong revenue growth for the March quarter and issued a positive outlook for FY27, with management highlighting growth opportunities in India, the US and …